SYSTEM; LUPUS ERYTHEMATOSUS
Clinical trials for SYSTEM; LUPUS ERYTHEMATOSUS explained in plain language.
Never miss a new study
Get alerted when new SYSTEM; LUPUS ERYTHEMATOSUS trials appear
Sign up with your email to follow new studies for SYSTEM; LUPUS ERYTHEMATOSUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stem cell therapy takes on lupus and more
Disease control Not yet recruitingThis early-phase study tests BCT301, a therapy made from special stem cells turned into immune cells, for people with hard-to-treat autoimmune diseases like lupus and scleroderma. The main goal is to check safety and find the right dose. Only 10 participants will be enrolled.
Matched conditions: SYSTEM; LUPUS ERYTHEMATOSUS
Phase: EARLY_PHASE1 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
Gene clues may unlock mystery of two blood disorders
Knowledge-focused Not yet recruitingThis study looks at two genes, IL-1β and IL-33, in 300 adults with either primary immune thrombocytopenia (ITP) or lupus-related low platelets. The goal is to see if these genes can help doctors tell the two conditions apart more easily. Participants will give a blood sample, and…
Matched conditions: SYSTEM; LUPUS ERYTHEMATOSUS
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated May 26, 2026 07:33 UTC